Form 4: Teva Pharmaceutical Industries: Chief Accounting Officer Amir Weiss Sells Shares

Amir Weiss, Chief Accounting Officer of Teva Pharmaceutical Industries, sold a total of 28,135 ordinary shares in two transactions on May 15 and 16, 2024.

Summary

• Amir Weiss, the Chief Accounting Officer of Teva Pharmaceutical Industries, sold 15,500 ordinary shares on May 15, 2024, at a weighted average price of $16.8011.
• On May 16, 2024, Weiss sold an additional 12,635 ordinary shares at a weighted average price of $16.6503.
• Following these transactions, Weiss directly owns 5,179 ordinary shares.
• The sales were executed in multiple transactions at varying prices within the ranges of $16.800 to $16.805 and $16.65 to $16.655, respectively.
• The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price upon request.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, which is common among publicly traded companies. It provides transparency into the transactions of company executives.

Stakeholder Impact

• The sale of shares by a high-ranking officer could be perceived negatively by some shareholders, potentially leading to speculation about the officer's confidence in the company's future performance.

Key Dates